PWM
ABBV icon

PRW Wealth Management’s AbbVie ABBV Stock Holding History

PRW Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-338
Closed -$27K – 60
2019
Q1 		$27K Sell
338
-260
-43% -$21.3K 0.03% 213
2018
Q4 		$55K Buy
+598
New +$52.6K 0.07% 126

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

PRW Wealth Management's ABBV Position: Q2 2019 in Review

PRW Wealth Management sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 338 shares — an estimated $27K sold.

PRW Wealth Management first reported a position in ABBV in Q4 2018 and held it in 2 quarters. The position peaked at $55K in Q4 2018. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • PRW Wealth Management reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
  • PRW Wealth Management sold 338 AbbVie shares in Q2 2019, an estimated $27K.
  • PRW Wealth Management first reported a position in AbbVie in Q4 2018 and held it in 2 quarters.
  • PRW Wealth Management's AbbVie position peaked at $55K in Q4 2018.
  • 2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on PRW Wealth Management's 13F filing for Q2 2019, filed 12 Aug 2019.